SpringWorks Therapeutics
$43.35
24H
Market Cap
Volume
Supply
Price Chart
About SpringWorks Therapeutics - SWTX
SpringWorks Therapeutics, Inc. is a biopharmaceutical company focused on developing targeted therapies for patients with severe rare diseases and cancer. They aim to advance their proprietary pipeline as well as leverage strategic collaborations to bring new treatments to market.
What are SpringWorks Therapeutics's core values and mission statement?
As of the time of this response, SpringWorks Therapeutics, Inc.'s mission is to develop and deliver important therapies to underserved patient populations. Their core values revolve around a patient-focused approach, fostering a culture of teamwork and collaboration, and a commitment to scientific excellence and integrity.
Who founded SpringWorks Therapeutics and when?
SpringWorks Therapeutics, Inc. was founded in 2017 by a team spun out of Pfizer.
Who leads SpringWorks Therapeutics?
As of the time of the inquiry, Saqib Islam serves as the Chief Executive Officer of SpringWorks Therapeutics, Inc.
Where is SpringWorks Therapeutics located, and what is its base country?
SpringWorks Therapeutics, Inc. is headquartered in Stamford, Connecticut, and its base country is the United States.
On which exchanges is SpringWorks Therapeutics traded?
SpringWorks Therapeutics, Inc. is traded on the Nasdaq Stock Market under the ticker symbol "SWTX."
Historical data
SpringWorks Therapeutics (SWTX) Price Live Data
The live price of SpringWorks Therapeutics (SWTX) is $43.35, with a trading volume of 346,182 in the last 24 hours. Wrapstocks updates the SWTX price in real-time. SpringWorks Therapeutics is down -1.49% in the last 24 hours. The company has a live market cap of $3,210,126,592.00 and a supply of 74,059,905 SWTX stocks.
SpringWorks Therapeutics (SWTX) is traded on NASDAQ Stock Exchange, and currently, the market is closed; trading will be resumed in 34 minutes.
